Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

LXRα/β Agonist (CAS 264206-85-1)

5.0(1)
Write a reviewAsk a question

Alternate Names:
GSK 3987
Application:
LXRα/β Agonist is a specific liver X receptor (LXR) dual agonist
CAS Number:
264206-85-1
Purity:
≥98%
Molecular Weight:
384.4
Molecular Formula:
C24H20N2O3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

LXRalpha/beta Agonist is a cell-permeable maleimide analog which acts as a potent and specific LXR (liver X receptor) dual agonist (EC50= 50 nM and 40 nM for the recruitment of SRC1 to LXRalpha and LXRbeta, respectively). It displays >50-fold selectivity for LXR over a panel of nuclear receptors, which include FXR, PPARalpha/gamma/delta, PXR, AR, ERalpha/beta, GR, and PR. This upregulates ABCA1-dependent transcriptional activity (EC50 = 80 nM) as well as inhibits LPS-stimulated secretion of the proinflammatory cytokine, IL-6, in THP-1 cells.


LXRα/β Agonist (CAS 264206-85-1) References

  1. Discovery of substituted maleimides as liver X receptor agonists and determination of a ligand-bound crystal structure.  |  Jaye, MC., et al. 2005. J Med Chem. 48: 5419-22. PMID: 16107141
  2. Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype.  |  Lund, EG., et al. 2006. Biochem Pharmacol. 71: 453-63. PMID: 16325781
  3. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.  |  Quinet, EM., et al. 2006. Mol Pharmacol. 70: 1340-9. PMID: 16825483
  4. Liver X receptor modulators: a review of recently patented compounds (2007 - 2009).  |  Li, X., et al. 2010. Expert Opin Ther Pat. 20: 535-62. PMID: 20302451
  5. Paeoniflorin acts as a liver X receptor agonist.  |  Lin, HR. 2013. J Asian Nat Prod Res. 15: 35-45. PMID: 23281636
  6. Liver X receptor modulators: a review of recently patented compounds (2009 - 2012).  |  Loren, J., et al. 2013. Expert Opin Ther Pat. 23: 1317-35. PMID: 23826715
  7. Chemical regulators of epithelial plasticity reveal a nuclear receptor pathway controlling myofibroblast differentiation.  |  Carthy, JM., et al. 2016. Sci Rep. 6: 29868. PMID: 27430378
  8. Ligands of Therapeutic Utility for the Liver X Receptors.  |  Komati, R., et al. 2017. Molecules. 22: PMID: 28067791
  9. Snail mediates crosstalk between TGFβ and LXRα in hepatocellular carcinoma.  |  Bellomo, C., et al. 2018. Cell Death Differ. 25: 885-903. PMID: 29230000
  10. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.  |  Rangaraju, S., et al. 2018. Mol Neurodegener. 13: 24. PMID: 29784049
  11. Synthesis and In Vitro Evaluation of Novel Liver X Receptor Agonists Based on Naphthoquinone Derivatives.  |  Nishioka, T., et al. 2019. Molecules. 24: PMID: 31779181
  12. Liver X receptors and skeleton: Current state-of-knowledge.  |  Goel, D. and Vohora, D. 2021. Bone. 144: 115807. PMID: 33333244
  13. Vitamin D and lumisterol derivatives can act on liver X receptors (LXRs).  |  Slominski, AT., et al. 2021. Sci Rep. 11: 8002. PMID: 33850196

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

LXRα/β Agonist, 10 mg

sc-221864
10 mg
$334.00